Search scope:
排序: Display mode:
Xin Du,Daobin Zhou
Frontiers of Medicine 2016, Volume 10, Issue 4, Pages 437-443 doi: 10.1007/s11684-016-0472-9
A phase II study (A2202) was performed to evaluate the efficacy and safety of JAK inhibitor ruxolitinib
Keywords: JAK ruxolitinib Chinese patients myelofibrosis
LIU Hongxing, TONG Chunrong, CAI Peng, GU Jiangying, LIN Yuehui, TENG Wen, WANG He, ZHANG Ying, ZHU Ping
Frontiers of Medicine 2008, Volume 2, Issue 3, Pages 309-313 doi: 10.1007/s11684-008-0059-1
Keywords: specific amplification essential thrombocythemia Single-tube bi-directional JAK2V617F-positive JAK2V617F
Title Author Date Type Operation
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential
Xin Du,Daobin Zhou
Journal Article